SCHEMBL23067904

SCHEMBL23067904

c1ccc(OCCOCCNCCOCCOc2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 10/20 0.70
DRD2 P14416 9/20 0.70
DRD3 P35462 7/20 0.70
GAA P10253 1/20 0.61
KDM4E B2RXH2 2/20 0.59
RECQL P46063 1/20 0.59
TSHR P16473 2/20 0.55
HTR1A P08908 1/20 0.54
ADRA1D P25100 1/20 0.54
ADRA1A P35348 1/20 0.54
ADRA1B P35368 1/20 0.54
KCNA3 P22001 1/20 0.54
LMNA P02545 1/20 0.54
HTR1D P28221 1/20 0.53
HTR1B P28222 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31650955 1.00 DRD4 (0.70) DRD4DRD2DRD3GAAKDM4E
SCHEMBL8938905 0.87 DRD4 (0.91) DRD4DRD2DRD3GAAHTR1A
SCHEMBL11087417 0.87 KCNA3 (0.70) DRD4DRD2DRD3KDM4ERECQL
SCHEMBL2481801 0.87 KCNA3 (0.70) DRD4DRD2DRD3KDM4ERECQL
SCHEMBL148066 0.87 KCNA3 (0.70) DRD4DRD2DRD3KDM4ERECQL
SCHEMBL10452423 0.87 KCNA3 (0.70) DRD4DRD2DRD3KDM4ERECQL
SCHEMBL466750 0.87 KCNA3 (0.70) DRD4DRD2DRD3KDM4ERECQL
SCHEMBL5067163 0.87 KCNA3 (0.70) DRD4DRD2DRD3KDM4ERECQL
SCHEMBL11352668 0.87 TSHR (0.67) DRD4DRD2DRD3KDM4ERECQL
SCHEMBL11348787 0.85 TSHR (0.65) DRD4DRD2DRD3KDM4ERECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12364978-B2 Anionic exchange-hydrophobic mixed mode chromatography resins BIO-RAD LABORATORIES, INC. (US) 2025-07-22 US claimed
US-20250345785-A1 ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS BIO RAD LABORATORIES INC (US) 2025-11-13 US disclosed
US-12364978-B2 Anionic exchange-hydrophobic mixed mode chromatography resins BIO-RAD LABORATORIES, INC. (US) 2025-07-22 US disclosed
US-20240261775-A1 ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS BIO-RAD LABORATORIES, INC. 2024-08-08 US disclosed
US-11896969-B2 Anionic exchange-hydrophobic mixed mode chromatography resins BIO-RAD LABORATORIES, INC. (US) 2024-02-13 US disclosed
US-20210069692-A1 ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS BIO-RAD LABORATORIES, INC. 2021-03-11 US disclosed
US-20210069692-A1 ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS BIO-RAD LABORATORIES, INC. 2021-03-11 US disclosed
WO-2021046284-A1 ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS BIO-RAD LABORATORIES, INC. (US) 2021-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250345785-A1 ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS ABCG2, SLC7A1, MSR1 DRD4 1739/4885DRD2 2750/4885DRD3 2422/4885
US-12364978-B2 Anionic exchange-hydrophobic mixed mode chromatography resins ABCG2, SLC7A1, MSR1 DRD4 1739/4885DRD2 2750/4885DRD3 2422/4885
US-20240261775-A1 ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS ABCG2, SLC7A1, MSR1 DRD4 1739/4885DRD2 2750/4885DRD3 2422/4885
US-20210069692-A1 ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS ABCG2, SLC7A1, MSR1 DRD4 1739/4885DRD2 2750/4885DRD3 2422/4885
US-11896969-B2 Anionic exchange-hydrophobic mixed mode chromatography resins ABCG2, SLC7A1, MSR1 DRD4 1739/4885DRD2 2750/4885DRD3 2422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.